Publication | Closed Access
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy
69
Citations
30
References
2018
Year
In MM, Arg-1 is mainly expressed by PMN-MDSC. PMN-MDSC and Arg-1 are reduced in vivo after lenalidomide but not bortezomib treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1